Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder
Masafumi Fukagawa,Keitaro Yokoyama,Fumihiko Koiwa,Masatomo Taniguchi,Tetsuo Shoji,Junichiro James Kazama,Hirotaka Komaba,Ryoichi Ando,Takatoshi Kakuta,Hideki Fujii,Msasaaki Nakayama,Yugo Shibagaki,Seiji Fukumoto,Naohiko Fujii,Motoshi Hattori,Akira Ashida,Kunitoshi Iseki,Takashi Shigematsu,Yusuke Tsukamoto,Yoshiharu Tsubakihara,Tadashi Tomo,Hideki Hirakata,Tadao Akizawa +22 more
TLDR
CKD-MBD Guideline Working Group, Japanese Society for Dialysis Therapy, and Tadao Akizawa thank the authors for their help and assistance in the development of this guideline.Abstract:
Masafumi Fukagawa, Keitaro Yokoyama, Fumihiko Koiwa, Masatomo Taniguchi, Tetsuo Shoji, Junichiro James Kazama, Hirotaka Komaba, Ryoichi Ando, Takatoshi Kakuta, Hideki Fujii, Msasaaki Nakayama, Yugo Shibagaki, Seiji Fukumoto, Naohiko Fujii, Motoshi Hattori, Akira Ashida, Kunitoshi Iseki, Takashi Shigematsu, Yusuke Tsukamoto, Yoshiharu Tsubakihara, Tadashi Tomo, Hideki Hirakata, and Tadao Akizawa for CKD-MBD Guideline Working Group, Japanese Society for Dialysis Therapyread more
Citations
More filters
Journal ArticleDOI
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Francesca Tentori,Mia Wang,Brian Bieber,Angelo Karaboyas,Yun Li,Stefan H. Jacobson,Vittorio E. Andreucci,Masafumi Fukagawa,Luc Frimat,David C. Mendelssohn,Friedrich K. Port,Ronald L. Pisoni,Bruce M. Robinson +12 more
TL;DR: In a large international sample of patients on hemodialysis, parathyroid hormone levels increased in most countries, and secondary hyperparathyroidism treatments changed over time, and very low and very high parathyro hormone levels were associated with adverse outcomes.
Journal ArticleDOI
An overview of regular dialysis treatment in Japan (as of 31 December 2012).
Shigeru Nakai,Norio Hanafusa,Ikuto Masakane,Masatomo Taniguchi,Takayuki Hamano,Tetsuo Shoji,Takeshi Hasegawa,Noritomo Itami,Kunihiro Yamagata,Toshio Shinoda,Junichiro James Kazama,Yuzo Watanabe,Takashi Shigematsu,Seiji Marubayashi,Osamu Morita,Atsushi Wada,Seiji Hashimoto,Kazuyuki Suzuki,Hidetomo Nakamoto,Naoki Kimata,Kenji Wakai,Naohiko Fujii,Satoshi Ogata,Kenji Tsuchida,Hiroshi Nishi,Kunitoshi Iseki,Yoshiharu Tsubakihara +26 more
TL;DR: The dialysis patient population has been growing every year in Japan; it was 310 007 at the end of 2012, which exceeded 310’000 for the first time, and the percentage of dialysis patients with diabetic nephropathy has been continuously increasing, whereas not only the percentage but also the actual number of dial renal failure patients with chronic glomerulonephritis has decreased.
Journal ArticleDOI
Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
Keitaro Yokoyama,Hideki Hirakata,Takashi Akiba,Masafumi Fukagawa,Masaaki Nakayama,Kenichi Sawada,Yuji Kumagai,Geoffrey A. Block +7 more
TL;DR: In patients with nondialysis-dependent CKD, 12-week treatment with ferric citrate hydrate resulted in significant reductions in serum phosphate and fibroblast growth factor-23 while simultaneously increasing serum iron parameters.
Journal ArticleDOI
Modulating macrophage activities to promote endogenous bone regeneration: Biological mechanisms and engineering approaches
TL;DR: This article encapsulate the immunomodulatory functions of macrophages during bone regeneration into three aspects, as sweeper, mediator and instructor, and systematically classify and discuss the emerging engineering strategies to recruit, activate and modulate the phenotype transition of Macrophages to exploit the power of endogenous macrophage to enhance the performance of engineered bone tissue.
Journal ArticleDOI
Japanese Society for Dialysis Therapy Clinical Guideline for “Maintenance Hemodialysis: Hemodialysis Prescriptions”
Yuzo Watanabe,Hideki Kawanishi,Kazuyuki Suzuki,Shigeru Nakai,Kenji Tsuchida,Kaoru Tabei,Takashi Akiba,Ikuto Masakane,Yoshiaki Takemoto,Tadashi Tomo,Noritomo Itami,Yasuhiro Komatsu,Motoshi Hattori,Michio Mineshima,Akihiro C. Yamashita,Akira Saito,Hidemune Naito,Hideki Hirakata,Jun Minakuchi +18 more
TL;DR: Thank you to Yuzo Watanabe, Hideki Kawanishi, Kazuyuki Suzuki, Shigeru Nakai, Kenji Tsuchida, Kaoru Tabei, Takashi Akiba, Ikuto Masakane, Yoshiaki Takemoto, Tadashi Tomo, Noritomo Itami, Yasuhiro Komatsu, Motoshi Hattori, Michio Mineshima, Akihiro Yamashita, Akira Saito, Hidemune Naito
References
More filters
Journal ArticleDOI
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Andrew S. Levey,Kai-Uwe Eckardt,Yusuke Tsukamoto,Adeera Levin,Josef Coresh,Jerome Rossert,Dick de Zeeuw,Thomas H. Hostetter,Norbert Lameire,Garabed Eknoyan +9 more
TL;DR: A survey and conference was conducted and a controversies conference was sponsored to provide a clear understanding to both the nephrology and nonnephrology communities of the evidence base for the definition and classification recommended by Kidney Disease Quality Outcome Initiative (K/DOQI).
Journal ArticleDOI
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
William G. Goodman,Jonathan G. Goldin,Beatriz D. Kuizon,Chun Yoon,Barbara Gales,Donna Sider,Yan Wang,Joanie Chung,Aletha Emerick,Lloyd E. Greaser,Robert Elashoff,Isidro B. Salusky +11 more
TL;DR: Coronary-artery calcification is common and progressive in young adults with end-stage renal disease who are undergoing dialysis who are undergoing dialysis.
Journal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
Journal ArticleDOI
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Geoffrey A. Block,Preston S. Klassen,J. Michael Lazarus,Norma J. Ofsthun,Edmund G. Lowrie,Glenn M. Chertow +5 more
TL;DR: Hyperphosphatemia and hyperparathyroidism were significantly associated with all-cause, cardiovascular, and fracture-related hospitalization, and the population attributable risk percentage for disorders of mineral metabolism was 17.5%, owing largely to the high prevalence of hyperph phosphatemia.
Journal ArticleDOI
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
TL;DR: This study concludes that a large percentage of hemodialysis patients who have a serum phosphorus level above 6.5 mg/dL and that this places them at increased risk of death, and supports the need for vigorous control of hyperphosphatemia to improve patient survival.
Related Papers (5)
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more